While some patients experience adverse drug reactions (ADRs) when taking medicines, others do not, and in some cases, others do not receive therapeutic benefits from treatment regardless of dosage. One reason for this inter-individual variation in response is differences in genes that code for proteins important in drug response. This has given rise to the field of Pharmacogenomics (PGx), which seeks to identify biomarkers that predict drug response and apply them in the provision of PGx-guided precision medicine. Following years of repeated Pharmacogenomics (PGx) research, which sought to identify biomarkers…
Read MoreWhy Africans and Europeans React To Medicines Differently: Zimbabwean Scientist Tests Effectiveness of Pharmacogenetics in African Populations
